|
INDUSTRY NEWS & EVENTS
NOVEMBER EVENTS: If you're attending the AAOS Real World Evidence Symposium on Orthobiologics on Nov. 4 in Washington, D.C., BCVG founder Dr. Scott Bruder will be there, too. The focus for the event will be “The Next Generation of Biologics: Use of Real-world Evidence.” From Nov. 17-19, Vice President James Petricek will be representing BCVG at the ICRS Summit on Joint Preservation in Miami, Fla. According to the organization, the summit will highlight "young active patients who wish to have an active lifestyle and preserve their native joints." Learn more at cartilage.org/icrs-summit-miami.
DON’T MISS “THE PITCH”: This webinar series features orthopedic and spine entrepreneurs who are seeking capital and making their pitch to a panel of experienced investors. It’s moderated by Anthony Viscogliosi and includes Dr. Bruder as a panelist. Do you want to be considered for a chance to be on “The Pitch”? OTW Broadcasting is looking for the next great orthopedic or spine product or service. Apply now to be considered for a future episode.
SAVE THE DATES: Dr. Bruder will be lecturing at the 8th annual ARMI Orthobiologics Conference Feb. 3-5 in Salt Lake City, Utah. Learn more and register at advancedregenmedinstitute.com. Plus, Bruder Consulting & Venture Group will be leading sessions on innovation and regulatory affairs during the Orthopaedic Research Society 2023 annual meeting Feb. 10-14 in Dallas, Texas. Learn more at ors.org.
|
Dr. Bruder was one of the editors of the new book "Orthobiologics: 
Steven Goldstein, Ph.D., is an Emeritus Professor of Orthopedic Surgery and Bioengineering at the University of Michigan, where he also earned his doctorate degree. Dr. Goldstein's large and diverse research program included studies ranging from fracture repair and total joint replacement to investigating the mechanisms associated with inherited or degenerative connective tissue disorders and the development of strategies for tissue regeneration. He is widely recognized as a seminal leader in these fields, has published more than 200 peer-reviewed papers and has received numerous awards for his investigations.
